Cargando…

Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors

OBJECTIVE: To study whether subvolumes with a high pre-chemoradiotherapy (CRT) FDG uptake could identify residual metabolically-active volumes (MAVs) post-CRT within individual esophageal tumors. Accurate identification will allow simultaneous integrated boost to these subvolumes at higher risk to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, W, Tan, S, Chen, W, Kligerman, S, Feigenberg, SJ, Zhang, H, Suntharalingam, M, Kang, M, D’Souza, WD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652953/ https://www.ncbi.nlm.nih.gov/pubmed/26594591 http://dx.doi.org/10.4172/2155-9619.1000226

Ejemplares similares

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

PET/CT planning during chemoradiotherapy for esophageal cancer
por: Seol, Ki Ho, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Impact of (18)F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
por: Vees, Hansjörg, et al.
Publicado: (2012)

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
por: Soydal, Çiğdem, et al.
Publicado: (2014)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2019)

Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT
por: Han, Dali, et al.
Publicado: (2019)

Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation
por: Toya, Ryo, et al.
Publicado: (2019)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
por: Gallamini, Andrea, et al.
Publicado: (2021)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
por: Parlak, Cem, et al.
Publicado: (2012)

Measuring distance from the incisors to the esophageal cancer by FDG PET/CT: endoscopy as the reference
por: Hsu, Szu-Wei, et al.
Publicado: (2022)

FDG PET/CT and Endoscopic Ultrasound for Preoperative T-Staging of Esophageal Squamous Cell Carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2023)

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

Multi-Institutional Validation of Two-Streamed Deep Learning Method for Automated Delineation of Esophageal Gross Tumor Volume Using Planning CT and FDG-PET/CT
por: Ye, Xianghua, et al.
Publicado: (2022)

External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
por: Valkema, Maria J., et al.
Publicado: (2023)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

FDG-PET/CT in infections: the imaging method of choice?
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2010)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy
por: Chen, Shang-Wen, et al.
Publicado: (2018)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Association of Esophageal Inflammation, Obesity and Gastroesophageal Reflux Disease: From FDG PET/CT Perspective
por: Wu, Yen-Wen, et al.
Publicado: (2014)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences
por: Shashi, Kumar K., et al.
Publicado: (2020)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer
por: Patel, N., et al.
Publicado: (2018)

You cannot oxidize what you cannot reach: Oxidative susceptibility of buried methionine residues
por: Kulczyk, Arkadiusz W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n56v8d477v2utoqflbp6mf9273